Advanced Search Results For "AND COVID-19 Subject OR COVID-19 pandemic Subject OR SARS-CoV-2 Subject OR SARS-CoV-2 Delta variant Subject OR SARS-CoV-2 Omicron variant Subject "
Your filters
Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study).
Publication Type: Academic Journal
Source(s): Frontiers in immunology [Front Immunol] 2022 Jun 23; Vol. 13, pp. 905585. Date of Electronic Publication: 2022 Jun 23 (Print Publication: 2022).
Abstract: Background: In Hungary, the pandemic waves in late 2021 and early 2022 were dominated by the Delta and Omicron SARS-CoV-2 variants, respectively. Booster vaccines were offered with one or two doses for the vulnerable population during these periods.Met...
Neutralization effect of plasma from vaccinated COVID-19 convalescents on SARS-CoV-2 Omicron variants.
Publication Type: Academic Journal
Source(s): Frontiers in Immunology; 9/29/2022, Vol. 13, p01-07, 7p
Abstract: Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, dow...
Dok3 restrains neutrophil production of calprotectin during TLR4 sensing of SARS-CoV-2 spike protein.
Publication Type: Academic Journal
Source(s): Frontiers in Immunology; 9/12/2022, Vol. 12, p1-14, 14p
Abstract: Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, dow...
A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines.
Publication Type: Academic Journal
Source(s): Frontiers in Immunology; 8/26/2022, Vol. 13, p1-24, 24p
Abstract: Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, dow...
Role of COVID-19 Vaccines in SARS-CoV-2 Variants.
Publication Type: Academic Journal
Source(s): Frontiers in Immunology; 5/20/2022, Vol. 13, p1-15, 15p
Abstract: Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, dow...
BNT162b2 Booster Vaccination Elicits Cross-Reactive Immunity Against SARS-CoV-2 Variants B.1.1.529 and B.1.617.2 in Convalescents of All Ages.
Publication Type: Academic Journal
Source(s): Frontiers in Immunology; 6/20/2022, Vol. 13, p1-11, 11p
Abstract: Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, dow...
Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19.
Publication Type: Academic Journal
Source(s): Frontiers in Immunology; 6/1/2022, Vol. 13, p1-19, 19p
Abstract: Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, dow...
At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant.
Publication Type: Academic Journal
Source(s): Frontiers in Immunology; 5/17/2022, Vol. 13, p1-10, 10p
Abstract: Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, dow...
SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance.
Publication Type: Academic Journal
Source(s): Frontiers in Immunology; 4/29/2022, Vol. 13, p1-13, 13p
Abstract: Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, dow...
Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern.
Publication Type: Academic Journal
Source(s): Frontiers in Immunology; 2/24/2022, Vol. 13, p1-9, 9p
Abstract: Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, dow...